tiprankstipranks
Advertisement
Advertisement

RLAY Stock Latest News

Relay Therapeutics price target raised to $29 from $28 at H.C. Wainwright
The FlyRelay Therapeutics price target raised to $29 from $28 at H.C. Wainwright
17d ago
RLAY
Relay Therapeutics price target raised to $31 from $28 at JPMorgan
PremiumThe Fly
Relay Therapeutics price target raised to $31 from $28 at JPMorgan
21d ago
RLAY
Relay Therapeutics price target raised to $25 from $21 at BofA
PremiumThe Fly
Relay Therapeutics price target raised to $25 from $21 at BofA
27d ago
RLAY
Relay Therapeutics price target raised to $26 from $21 at Citizens
PremiumThe Fly
Relay Therapeutics price target raised to $26 from $21 at Citizens
27d ago
RLAY
Relay Therapeutics: Buy Rating Reaffirmed with Unchanged $29 Price Target on Multiple Upcoming Clinical and Regulatory Catalysts
PremiumRatings
Relay Therapeutics: Buy Rating Reaffirmed with Unchanged $29 Price Target on Multiple Upcoming Clinical and Regulatory Catalysts
30d ago
RLAY
Boris Peaker Reiterates Buy on Relay Therapeutics, Citing Advancing Zovegalisib Phase III Program, Rich 2026–2027 Catalyst Calendar, and Solid Cash Position Supporting Favorable Risk‑Reward
PremiumRatingsBoris Peaker Reiterates Buy on Relay Therapeutics, Citing Advancing Zovegalisib Phase III Program, Rich 2026–2027 Catalyst Calendar, and Solid Cash Position Supporting Favorable Risk‑Reward
1M ago
RLAY
Relay Therapeutics price target raised to $30 from $27 at Barclays
Premium
The Fly
Relay Therapeutics price target raised to $30 from $27 at Barclays
1M ago
RLAY
Analyst Reiterates Buy on Relay Therapeutics, Citing Lead Asset Zovegalisib’s Phase 3 Upside and Strong Cash Runway into 2029
Premium
Ratings
Analyst Reiterates Buy on Relay Therapeutics, Citing Lead Asset Zovegalisib’s Phase 3 Upside and Strong Cash Runway into 2029
1M ago
RLAY
Relay Therapeutics Expands ATM Equity Offering Agreement
PremiumCompany Announcements
Relay Therapeutics Expands ATM Equity Offering Agreement
1M ago
8K
RLAY
Private Markets: Chai Discovery, Etched land major rounds
PremiumThe Fly
Private Markets: Chai Discovery, Etched land major rounds
1M ago
J
AI
Relay Therapeutics price target raised to $31 from $22 at Goldman Sachs
PremiumThe Fly
Relay Therapeutics price target raised to $31 from $22 at Goldman Sachs
2M ago
RLAY
Relay Therapeutics initiated with a Buy at Canaccord on zovegalisib’s potential
PremiumThe Fly
Relay Therapeutics initiated with a Buy at Canaccord on zovegalisib’s potential
2M ago
RLAY
Relay Therapeutics initiated with a Buy at Canaccord
PremiumThe FlyRelay Therapeutics initiated with a Buy at Canaccord
2M ago
RLAY
Relay Therapeutics initiated with an Overweight at JPMorgan
Premium
The Fly
Relay Therapeutics initiated with an Overweight at JPMorgan
2M ago
RLAY
Relay Therapeutics: Buy Rating on Undervalued Zovegalisib Franchise with Multi‑Billion Peak Sales Potential in Breast Cancer and Vascular Anomalies
Premium
Ratings
Relay Therapeutics: Buy Rating on Undervalued Zovegalisib Franchise with Multi‑Billion Peak Sales Potential in Breast Cancer and Vascular Anomalies
2M ago
RLAY
Relay Therapeutics Targets NRAS Cancers With New First-in-Human Trial
PremiumCompany Announcements
Relay Therapeutics Targets NRAS Cancers With New First-in-Human Trial
2M ago
RLAY
Relay Therapeutics Expands Authorized Shares at 2026 Meeting
PremiumCompany Announcements
Relay Therapeutics Expands Authorized Shares at 2026 Meeting
3M ago
8K
RLAY
Relay Therapeutics price target raised to $26 from $22 at Guggenheim
PremiumThe Fly
Relay Therapeutics price target raised to $26 from $22 at Guggenheim
3M ago
RLAY
Relay Therapeutics price target raised to $28 from $25 at H.C. Wainwright
PremiumThe Fly
Relay Therapeutics price target raised to $28 from $25 at H.C. Wainwright
3M ago
RLAY
Citizens biotech analysts hold a dinnermeeting at ASCO
PremiumThe FlyCitizens biotech analysts hold a dinnermeeting at ASCO
4M ago
AZN
LLY
Relay Therapeutics Announces Major Underwritten Equity Offering
Premium
Company Announcements
Relay Therapeutics Announces Major Underwritten Equity Offering
4M ago
8K
RLAY
Relay Therapeutics 22.9M share Secondary priced at $12.00
Premium
The Fly
Relay Therapeutics 22.9M share Secondary priced at $12.00
4M ago
RLAY

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >